Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease

BACKGROUND: A high incidence of interstitial lung disease (ILD) has been reported in patients with advanced non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), particularly in Japanese populations. A previous report from our labora...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawase, Shigeo, Hattori, Noboru, Ishikawa, Nobuhisa, Horimasu, Yasushi, Fujitaka, Kazunori, Furonaka, Osamu, Isobe, Takeshi, Miyoshi, Seigo, Hamada, Hironobu, Yamane, Takashi, Yokoyama, Akihito, Kohno, Nobuoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160959/
https://www.ncbi.nlm.nih.gov/pubmed/21791074
http://dx.doi.org/10.1186/1465-9921-12-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160959/
https://www.ncbi.nlm.nih.gov/pubmed/21791074
http://dx.doi.org/10.1186/1465-9921-12-97

Ejemplares similares